Literature DB >> 19373499

Epidemiological typing of clinical isolates of Achromobacter xylosoxidans: comparison of phenotypic and genotypic methods.

M Kaur1, P Ray, M Bhatty, M Sharma.   

Abstract

The purpose of this paper is to evaluate the utility of different typing methods for Achromobacter xylosoxidans clinical isolates. Ninety-two blood culture isolates of A. xylosoxidans subsp. xylosoxidans were collected over a 25-month period. The typeability, discriminatory power and reproducibility of commonly used phenotypic and genotypic methods, such as resistotyping, plasmid profiling, whole-cell protein fingerprinting, random amplification of polymorphic DNA (RAPD) and pulsed-field gel electrophoresis (PFGE), were compared. All 92 isolates were typeable by all of the methods used, with comparable reproducibility. PFGE showed the highest discriminatory power (98.9%), but whole-cell protein profiling showed better correlation with epidemiological data without significant loss in discriminatory power (94%). Whole-cell protein profiling is a reliable epidemiological tool for the analysis of A. xylosoxidans; PFGE is the most discriminatory.

Entities:  

Mesh:

Year:  2009        PMID: 19373499     DOI: 10.1007/s10096-009-0740-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

1.  Comparison of polymerase chain reaction and pulsed-field gel electrophoresis for the epidemiological typing of Alcaligenes xylosoxidans subsp. xylosoxidans in a burn unit.

Authors:  Y H Lin; P Y Liu; Z Y Shi; Y J Lau; B S Hu
Journal:  Diagn Microbiol Infect Dis       Date:  1997-08       Impact factor: 2.803

2.  Characteristics of Achromobacter xylosoxidans bacteremia in northern Taiwan.

Authors:  Shian-Sen Shie; Ching-Tai Huang; Hsieh-Shong Leu
Journal:  J Microbiol Immunol Infect       Date:  2005-08       Impact factor: 4.399

3.  A pseudoepidemic of Alcaligenes xylosoxidans attributable to contaminated saline.

Authors:  E V Granowitz; S L Keenholtz
Journal:  Am J Infect Control       Date:  1998-04       Impact factor: 2.918

Review 4.  Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature.

Authors:  J M Duggan; S J Goldstein; C E Chenoweth; C A Kauffman; S F Bradley
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

5.  Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center.

Authors:  Sabine Van Daele; Rita Verhelst; Geert Claeys; Gerda Verschraegen; Hilde Franckx; Leen Van Simaey; Catharine de Ganck; Frans De Baets; Mario Vaneechoutte
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 6.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

7.  Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.

Authors:  J W Krzewinski; C D Nguyen; J M Foster; J L Burns
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

8.  Alcaligenes xylosoxidans bacteremia: clinical features and microbiological characteristics of isolates.

Authors:  Ren-Wen Tsay; Li-Chen Lin; Chien-Shun Chiou; Jui-Cheng Liao; Chang-Hua Chen; Chun-Eng Liu; Tzuu-Guang Young
Journal:  J Microbiol Immunol Infect       Date:  2005-06       Impact factor: 4.399

9.  Epidemiological typing of Alcaligenes xylosoxidans subsp. xylosoxidans by antibacterial susceptibility testing, fatty acid analysis, PAGE of whole-cell protein and pulsed-field gel electrophoresis.

Authors:  M Knippschild; R Ansorg
Journal:  Zentralbl Bakteriol       Date:  1998-07

10.  Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone.

Authors:  M Kanellopoulou; S Pournaras; H Iglezos; N Skarmoutsou; E Papafrangas; A N Maniatis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

View more
  3 in total

1.  Achromobacter xylosoxidans infection presenting as a pulmonary nodule mimicking cancer.

Authors:  Stephanie L Claassen; Jason M Reese; Vincent Mysliwiec; Steven D Mahlen
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

2.  Achromobacter spp. bacteremia outbreak related to contaminated furosemide ampoules.

Authors:  Rajalakshmi Arjun; Kalpana E John; Vettakkara Kandy Muhammed Niyas; Sreerekha R Nair; Viji Mohan; Raveendran Sarala Ratheesh
Journal:  Infez Med       Date:  2021-09-10

3.  Achromobacter Xylosoxidans Bloodstream Infection in Elderly Patient with Hepatocellular Carcinoma: Case Report and Review of Literature.

Authors:  Kausalya Raghuraman; Nishat H Ahmed; Frincy K Baruah; Rajesh K Grover
Journal:  J Lab Physicians       Date:  2015 Jul-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.